eMoney Advisor vs. Nitrogen Growth Platform

Overview
ProductRatingMost Used ByProduct SummaryStarting Price
eMoney Advisor
Score 9.8 out of 10
N/A
eMoney Advisor headquartered in Radnor offers an investment portfolio management application for financial advisors.N/A
Nitrogen Growth Platform
Score 5.8 out of 10
N/A
Nitrogen Growth Platform (formerly Riskalyze) is an investment portfolio management software platform from the company of the same name in Auburn.
$395
per month
Pricing
eMoney AdvisorNitrogen Growth Platform
Editions & Modules
No answers on this topic
No answers on this topic
Offerings
Pricing Offerings
eMoney AdvisorNitrogen Growth Platform
Free Trial
NoNo
Free/Freemium Version
NoNo
Premium Consulting/Integration Services
NoNo
Entry-level Setup FeeNo setup feeNo setup fee
Additional Details
More Pricing Information
Community Pulse
eMoney AdvisorNitrogen Growth Platform
Considered Both Products
eMoney Advisor

No answer on this topic

Nitrogen Growth Platform
Chose Nitrogen Growth Platform
Trading software called Irebal which was part of TD and is now available for free at Schwab is a much superior trading platform than their autopilot which costs $500+ plus per month. Risk questionnaire is moderately priced but is of good value for a practice looking for …
User Ratings
eMoney AdvisorNitrogen Growth Platform
Likelihood to Recommend
10.0
(1 ratings)
6.0
(1 ratings)
User Testimonials
eMoney AdvisorNitrogen Growth Platform
Likelihood to Recommend
eMoney Advisor
Financial planning provides clients with benchmarks for achieving their financial goals regardless of whether their needs are simple or complex. The client portal allows clients to access their data through an efficient and transparent process, which helps strengthen the relationship between client and firm. The account aggregation software gives clients a complete picture of all transactions and details.
Read full review
Nitrogen Wealth, Inc.
From experience, be very careful of the sales department attempting to sell you autopilot or additional licenses that they will tell you, you dont have to pay for because your assets with one of their fund partners qualifes you for free licenses. In my opinion, I woudn't say we were scammed but were sold on this fact, and they over subscribed us licenses includding one Autopilot licensed which we didn't need. Now, that the fund drop out of the NTF program they are full boating us the $1300 per month for licenses. Their remedy was for us to sign a new 12 month agreement, and they dropped the Autopilot license. Since the CEO has left this year, the name and sadly the company has changed.
Read full review
Pros
eMoney Advisor
  • Account Aggregation
  • Investment Goals
  • Social Security Analyzer
Read full review
Nitrogen Wealth, Inc.
No answers on this topic
Cons
eMoney Advisor
  • More concise reports
  • Better account aggregation software
  • Better communication with staff on updates
Read full review
Nitrogen Wealth, Inc.
  • More ethical sales team
  • Autopilot trading license is way overpriced
  • trading software slow upload times
Read full review
Alternatives Considered
eMoney Advisor
Better dashboard for Advisors to uncover insights and new investment possibilities and monitor investment allocation strategies that take actions to improve clients' retirement success. The system allows the firm to be more intuitive with integrations, providing the firm the ability to work more efficiently with less downtime compared to the other systems we evaluated
Read full review
Nitrogen Wealth, Inc.
Trading software called Irebal which was part of TD and is now available for free at Schwab is a much superior trading platform than their autopilot which costs $500+ plus per month. Risk questionnaire is moderately priced but is of good value for a practice looking for efficient way of ascertaining clients risk tolerance
Read full review
Return on Investment
eMoney Advisor
  • Client referrals
  • Clients willing to invest new money
  • Stronger bond between client and firm
Read full review
Nitrogen Wealth, Inc.
  • Has greatly assisted in the risk questionnaire area
Read full review
ScreenShots